Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows an updated Revision tag from v3.6.5 to v3.6.6. This appears to be a minor platform update and does not change the study details or how users interact with the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision has been updated to v3.6.5, replacing v3.6.4. This reflects an updated document state rather than changes to the study details or overall content.SummaryDifference0.0%

- Check49 days agoChange DetectedA publication citation in the Publications section was updated to reflect a 2026 July version with a DOI, replacing the earlier print/online-ahead-of-print entry. This is a bibliographic update rather than a change to study data or conduct.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small update to the study record.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now displays revision v3.6.2, replacing v3.6.0, indicating a small maintenance update to the page's version tag without altering study content.SummaryDifference0.1%

- Check92 days agoChange DetectedRecruitment status now shows the study is not currently enrolling participants. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page revision note confirms the latest version.SummaryDifference0.4%

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.